You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
11 August 2026 - Italian pharmaceutical company Alfasigma S.p.A. announced on Tuesday that it has entered into an agreement with SEVER Life Sciences B.V. to acquire 100% of Nordic Group B.V. and its subsidiaries, expanding its specialty pharmaceutica...
11 August 2026 - Dermatology company Galderma (SWX:GALD) said on Tuesday that it has received European Union approval under the Medical Device Regulation for Restylane Shaype, a hyaluronic acid injectable for temporary augmentation of the chin region...
11 August 2026 - Clinical-stage pharmaceutical company SoftOx Solutions AS (Euronext Growth Oslo:SOFTX) announced on Tuesday that the first patient has been dosed in the proof-of-concept phase of its SIS-03 clinical programme. The Phase 2a patient tr...
11 August 2026 - Swedish medical device company Acarix AB (FN STO:ACARIX) (OTCQB:ACIXF) announced on Monday that the CADScor System has received regulatory approval from the Emirates Drug Establishment (EDE) and the Ministry of Health and Prevention ...
11 August 2026 - Kodiak Sciences Inc (Nasdaq:KOD), a precommercial retina-focused biotechnology company, announced on Monday that the first patients have been enrolled in the global Phase 3 ALTO trial evaluating KSI-501 in patients with diabetic macu...
10 August 2026 - Labcorp (NYSE: LH), a provider of comprehensive laboratory services, disclosed on Monday that it has received U.S. Food and Drug Administration approval for its PGDx elio tissue complete CDx as a companion diagnostic to identify pati...
10 August 2026 - BeOne Medicines Ltd (Nasdaq: ONC) (HKEX: 06160;) (SSE: 688235) and Revolution Medicines Inc (Nasdaq: RVMD) announced on Monday that the two oncology companies have entered a multi-part collaboration to develop combinations of selecte...